Glenmark Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glenmark Pharmaceuticals Ltd with three other
companies in this sector in INDIA :
Jubilant Life Sciences Limited
sales of 91.54 billion Indian Rupees [US$1.24 billion]
of which 62%
Torrent Pharmaceuticals Limited
(79.39 billion Indian Rupees [US$1.08 billion]
of which 100%
was Generic Formulation Business), and
Alkem Laboratories Ltd
(83.44 billion Indian Rupees [US$1.13 billion]
During the year ended March of 2020, sales at
Glenmark Pharmaceuticals Ltd were 106.41 billion Indian Rupees (US$1.44 billion).
increase of 7.9%
versus 2019, when the company's sales were 98.65 billion Indian Rupees .